Around 422 million people across the globe suffer from diabetes. Diabetic patients have to check their blood sugar level several times a day, by pricking their finger with a lancet. This is very painful and uncomfortable for the patients, which results in less frequent testing and thereby affects the control of blood sugar levels. Therefore, many companies are developing needle-free alternatives that eliminates the painful procedure.
MARKET DYNAMICS
Needle free diabetes care market is anticipated to grow in the forecast period owing to rise in the geriatric population, increasing prevalence of diabetic population, high incidence of obesity, and change in food habits. Moreover, technological advancements for diabetes care by market players is likely to create opportunity during the forecast period.
MARKET SCOPE
The "Global Needle Free Diabetes Care Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of needle free diabetes care market with detailed market segmentation by device type, end user and geography. The global needle free diabetes care market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading needle free diabetes care market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global needle free diabetes care market is segmented on the basis of device type and end user. Based on device type, the market is segmented as treatment devices, and diagnostics devices. Based on end user, the market is segmented as diagnostic centers, hospitals and clinics, and consumer.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global needle free diabetes care market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The needle free diabetes care market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting needle free diabetes care market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the needle free diabetes care market in these regions.
MARKET PLAYERS
The report covers key developments in the needle free diabetes care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from needle free diabetes care market are anticipated to lucrative growth opportunities in the future with the rising demand for needle free diabetes care in the global market. Below mentioned is the list of few companies engaged in the needle free diabetes care market.
The report also includes the profiles of key needle free diabetes care market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Zogenix, Inc.
- 3M
- Antares Pharma Inc.
- Glide Pharmaceutical Technologies Ltd.
- Injex Pharma AG
- Pharmajet, Inc.
- Bioject Medical Technologies, Inc.
- Medtronic, Inc.
- Johnson and Johnson, Inc.
- Pancreum LLC